{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:41:50Z","timestamp":1794220910334,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13195-018-0366-y","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:48:20Z","timestamp":1522802900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)"],"prefix":"10.1186","volume":"10","author":[{"given":"Matteo","family":"Bauckneht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chincarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Girtler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Grazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Efeturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmario","family":"Sambuceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"366_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol."},{"key":"366_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00234-012-1005-0","volume":"54","author":"Y Liu","year":"2012","unstructured":"Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, et al. Education increases reserve against Alzheimer\u2019s disease\u2014evidence from structural MRI analysis. Neuroradiology. 2012;54:929\u201338.","journal-title":"Neuroradiology."},{"key":"366_CR3","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1212\/01.wnl.0000327670.62378.c0","volume":"71","author":"V Garibotto","year":"2008","unstructured":"Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, et al. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology. 2008;71:1342\u20139.","journal-title":"Neurology."},{"key":"366_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2967\/jnumed.112.113928","volume":"54","author":"S Morbelli","year":"2013","unstructured":"Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BN, et al. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project. J Nucl Med. 2013;54:894\u2013902.","journal-title":"J Nucl Med."},{"key":"366_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448\u201360.","journal-title":"J Int Neuropsychol Soc."},{"key":"366_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","volume":"60","author":"G Ch\u00e9telat","year":"2003","unstructured":"Ch\u00e9telat G, Desgranges B, De la Sayette V, Viadre F, Eustache F, Baron JC. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease? Neurology. 2003;60:1374\u20137.","journal-title":"Neurology."},{"key":"366_CR7","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1001\/archneur.62.11.1728","volume":"62","author":"D Anchisi","year":"2005","unstructured":"Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol. 2005;62:1728\u201333.","journal-title":"Arch Neurol."},{"key":"366_CR8","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A, Grimmer T, Rimenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET. J Nucl Med. 2005;46:1625\u201332.","journal-title":"J Nucl Med."},{"key":"366_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/156720510791162368","volume":"7","author":"M Pagani","year":"2010","unstructured":"Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A, et al. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Curr Alzheimer Res. 2010;7:287\u201394.","journal-title":"Curr Alzheimer Res."},{"key":"366_CR10","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00259-017-3790-5","volume":"44","author":"S Morbelli","year":"2017","unstructured":"Morbelli S, Bauckneht M, Arnaldi D, Picco A, Pardini M, Brugnolo A, et al. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer\u2019s disease (AD) patients at the mild cognitive impairment (MCI) stage. Eur J Nucl Med Mol Imaging. 2017;44:2073\u201383.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"366_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11:1006\u201312.","journal-title":"Lancet Neurol."},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2017.06.016","volume":"59","author":"EM Arenaza-Urquijo","year":"2017","unstructured":"Arenaza-Urquijo EM, Bejanin A, Gonneaud J, Wirth M, La Joie R, Mutlu J, et al. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Neurobiol Aging. 2017;59:72\u20139.","journal-title":"Neurobiol Aging."},{"key":"366_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11682-016-9640-4","volume":"11","author":"DM Rentz","year":"2017","unstructured":"Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA. Cognitive resilience in clinical and preclinical Alzheimer\u2019s disease: the association of amyloid and tau burden on cognitive performance. Brain Imaging Behav. 2017;11:383\u201390.","journal-title":"Brain Imaging Behav."},{"key":"366_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1212\/WNL.0b013e31828970c2","volume":"80","author":"M Ewers","year":"2013","unstructured":"Ewers M, Insel PS, Stern Y, Weiner MW, Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013;80:1194\u2013201.","journal-title":"Neurology"},{"key":"366_CR15","first-page":"239","volume":"4","author":"S Morbelli","year":"2014","unstructured":"Morbelli S, Nobili F. Cognitive reserve and clinical expression of Alzheimer\u2019s disease: evidence and implications for brain PET imaging. Am J Nucl Med Mol Imaging. 2014;4:239\u201347.","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"366_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4329\/wjr.v7.i12.475","volume":"7","author":"M Bauckneht","year":"2015","unstructured":"Bauckneht M, Picco A, Nobili F, Morbelli S. Amyloid positron emission tomography and cognitive reserve. World J Radiol. 2015;7:475\u201383.","journal-title":"World J Radiol."},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement."},{"key":"366_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S1092852900016151","volume":"13","author":"RC Petersen","year":"2008","unstructured":"Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008;13:45\u201353.","journal-title":"CNS Spectr."},{"key":"366_CR19","unstructured":"Spinnler H, Tognoni G, Italian Group on the Neuropsychological Study of Aging. Italian standardization and classification of neuropsychological tests [in Italian]. Ital J Neurol Sci. 1987;(Suppl 8):1\u2013120."},{"key":"366_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuroimage.2016.07.043","volume":"141","author":"M Pagani","year":"2016","unstructured":"Pagani M, Giuliani A, \u00d6berg J, Chincarini A, Morbelli S, Brugnolo A, et al. Predicting the transition from normal aging to Alzheimer\u2019s disease: a statistical mechanistic evaluation of FDG-PET data. Neuroimage. 2016;141:282\u201390.","journal-title":"Neuroimage."},{"key":"366_CR21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. European Task Force on Age-Related White Matter. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318\u201322.","journal-title":"Stroke."},{"key":"366_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.STR.14.3.399","volume":"14","author":"C Loeb","year":"1983","unstructured":"Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke. 1983;14:399\u2013401.","journal-title":"Stroke."},{"key":"366_CR23","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42:2672\u2013713.","journal-title":"Stroke."},{"key":"366_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, N\u00e5gren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103\u201310.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","volume":"57","author":"S Minoshima","year":"2016","unstructured":"Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, et al. SNMMI Procedure Standard\/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. J Nucl Med. 2016;57:1316\u201322.","journal-title":"J Nucl Med"},{"key":"366_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","volume":"52","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, et al. Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52:1210\u20137.","journal-title":"J Nucl Med."},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","volume":"41","author":"SM Landau","year":"2014","unstructured":"Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ. Alzheimer\u2019s Disease Neuroimaging Initiative. Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers. Eur J Nucl Med Mol Imaging. 2014;41:1398\u2013407.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3233\/JAD-160232","volume":"54","author":"A Chincarini","year":"2016","unstructured":"Chincarini A, Sensi F, Rei L, Bossert I, Morbelli S, Guerra UP, Frisoni G, et al. Alzheimer\u2019s Disease Neuroimaging Initiative. Standardized uptake value ratio-independent evaluation of brain amyloidosis. J Alzheimers Dis. 2016;54:1437\u201357.","journal-title":"J Alzheimers Dis"},{"key":"366_CR29","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914\u201322.","journal-title":"Neurology."},{"key":"366_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/jcbfm.1993.4","volume":"13","author":"KJ Friston","year":"1993","unstructured":"Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab. 1993;13:5\u201314.","journal-title":"J Cereb Blood Flow Metab."},{"key":"366_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","volume":"12","author":"PA Della Rosa","year":"2014","unstructured":"Della Rosa PA, Cerami C, Gallivanone F, Prestia A, Caroli A, Castiglioni I, et al. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12:575\u201393.","journal-title":"Neuroinformatics."},{"key":"366_CR32","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/hbm.20718","volume":"30","author":"SB Eickhoff","year":"2009","unstructured":"Eickhoff SB, Laird AR, Grefkes C, Wang LE, Zilles K, Fox PT. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp. 2009;30:2907\u201326.","journal-title":"Hum Brain Mapp."},{"key":"366_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140311","volume":"10","author":"A Ishiki","year":"2015","unstructured":"Ishiki A, Okamura N, Furukawa K, Furumoto S, Harada R, Tomita N, et al. Longitudinal assessment of tau pathology in patients with Alzheimer\u2019s disease using [18F]THK-5117 positron emission tomography. PLoS One. 2015;10:e0140311.","journal-title":"PLoS One."},{"key":"366_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018;38:530\u201343.","journal-title":"J Neurosci."},{"key":"366_CR35","doi-asserted-by":"publisher","unstructured":"Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, et al. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer\u2019s disease dementia. Mol Psychiatry. 2017. \n                    https:\/\/doi.org\/10.1038\/mp.2017.108\n                    \n                  .","DOI":"10.1038\/mp.2017.108"},{"key":"366_CR36","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139:1551\u201367.","journal-title":"Brain."},{"key":"366_CR37","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2967\/jnumed.116.184309","volume":"58","author":"M Pagani","year":"2017","unstructured":"Pagani M, Giuliani A, \u00d6berg J, De Carli F, Morbelli S, Girtler N, et al. Progressive disintegration of brain networking from normal aging to Alzheimer disease: analysis of independent components of 18F-FDG PET data. J Nucl Med. 2017;58:1132\u20139.","journal-title":"J Nucl Med."},{"key":"366_CR38","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00259-017-3634-3","volume":"44","author":"N Torosyan","year":"2017","unstructured":"Torosyan N, Mason K, Dahlbom M, Silverman DHS, Alzheimer\u2019s Disease Neuroimaging Initiative. Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline. Eur J Nucl Med Mol Imaging. 2017;44:1355\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"366_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clinph.2004.09.001","volume":"116","author":"F Nobili","year":"2005","unstructured":"Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, et al. Resting SPECT-neuropsychology correlation in very mild Alzheimer\u2019s disease. Clin Neurophysiol. 2005;116:364\u201375.","journal-title":"Clin Neurophysiol."},{"key":"366_CR40","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00415-008-0897-4","volume":"255","author":"F Nobili","year":"2008","unstructured":"Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, et al. Brain SPECT in subtypes of mild cognitive impairment: findings from the DESCRIPA multicenter study. J Neurol. 2008;255:1344\u201353.","journal-title":"J Neurol."},{"key":"366_CR41","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","volume":"39","author":"R Ossenkoppele","year":"2012","unstructured":"Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, et al. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2012;39:990\u20131000.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"366_CR42","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/WNL.0000000000002490","volume":"86","author":"P Vemuri","year":"2016","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, et al. Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study. Neurology. 2016;86:1128\u201335.","journal-title":"Neurology."},{"key":"366_CR43","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1056\/NEJMoa022252","volume":"348","author":"J Verghese","year":"2003","unstructured":"Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003;348:2508\u201316.","journal-title":"N Engl J Med."},{"key":"366_CR44","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamaneurol.2017.0244","volume":"74","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Knopman DS, Lesnick TG, Przybelski SA, Mielke MM, Graff-Radford J, et al. Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals. JAMA Neurol. 2017;74:718\u201326.","journal-title":"JAMA Neurol."},{"key":"366_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-013-1226-2","volume":"127","author":"DA Bennett","year":"2014","unstructured":"Bennett DA, Arnold SE, Valenzuela MJ, Brayne C, Schneider JA. Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathol. 2014;127:137\u201350.","journal-title":"Acta Neuropathol."},{"key":"366_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081877","volume":"8","author":"P Elwood","year":"2013","unstructured":"Elwood P, Galante J, Pickering J, Palmer S, Bayer A, Ben-Shlomo Y, et al. Healthy lifestyles reduce the incidence of chronic diseases and dementia: evidence from the Caerphilly cohort study. PLoS One. 2013;8:e81877.","journal-title":"PLoS One."},{"key":"366_CR47","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","volume":"64","author":"L Mosconi","year":"2005","unstructured":"Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology. 2005;64:1860\u20137.","journal-title":"Neurology."},{"key":"366_CR48","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ de Leon","year":"2001","unstructured":"de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose\/positron-emission tomography (FDG\/PET). Proc Natl Acad Sci U S A. 2001;98:10966\u201371.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"366_CR49","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1212\/WNL.50.6.1585","volume":"50","author":"V Ib\u00e1\u00f1ez","year":"1998","unstructured":"Ib\u00e1\u00f1ez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer\u2019s disease. Neurology. 1998;50:1585\u201393.","journal-title":"Neurology."}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0366-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-018-0366-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0366-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T19:45:50Z","timestamp":1554234350000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0366-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0366-y","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional review board of our memory clinic, and all subjects signed an informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SM acted as a consultant for Eli Lilly in 2014 and for Avid Radiopharmaceuticals in 2016. FN acted as a consultant for Eli Lilly in 2014. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}